nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Agent specific effects of anticoagulant induced alopecia
|
Weyand, Angela C. |
|
|
1 |
1 |
p. 90-92 |
artikel |
2 |
Application of different lupus anticoagulant diagnostic algorithms to the same assay data leads to interpretive discrepancies in some samples
|
Moore, Gary W. |
|
|
1 |
1 |
p. 62-68 |
artikel |
3 |
Combined study of ADAMTS13 and complement genes in the diagnosis of thrombotic microangiopathies using next‐generation sequencing
|
Fidalgo, Teresa |
|
|
1 |
1 |
p. 69-80 |
artikel |
4 |
Cost‐minimization analysis of venous thromboembolism diagnosis: Comparison of standalone imaging with a strategy incorporating D‐dimer for exclusion of venous thromboembolism
|
Verma, Karan |
|
|
1 |
1 |
p. 57-61 |
artikel |
5 |
Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis
|
Khorana, Alok A. |
|
|
1 |
1 |
p. 14-22 |
artikel |
6 |
Endothelial barrier protective properties of low molecular weight heparin: A novel potential tool in the prevention of cancer metastasis?
|
Kevane, Barry |
|
|
1 |
1 |
p. 23-32 |
artikel |
7 |
Hello Research and Practice in Thrombosis and Haemostasis
|
Cushman, Mary |
|
|
1 |
1 |
p. 5 |
artikel |
8 |
Home infusion teaching practices at federally funded hemophilia treatment centers in the United States of America
|
Santaella, Maria E. |
|
|
1 |
1 |
p. 81-89 |
artikel |
9 |
Impact of World Thrombosis Day campaign
|
Wendelboe, Aaron M. |
|
|
1 |
1 |
p. 138-141 |
artikel |
10 |
ISSUE INFORMATION
|
|
|
|
1 |
1 |
p. 1-2 |
artikel |
11 |
Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases
|
Deguchi, Hiroshi |
|
|
1 |
1 |
p. 33-40 |
artikel |
12 |
Minor plasma lipids modulate clotting factor activities and may affect thrombosis risk
|
Deguchi, Hiroshi |
|
|
1 |
1 |
p. 93-102 |
artikel |
13 |
Occult cancer detection in venous thromboembolism: the past, the present, and the future
|
Khan, Faizan |
|
|
1 |
1 |
p. 9-13 |
artikel |
14 |
Phenotype analysis and clinical management in a large family with a novel truncating mutation in RASGRP2, the CalDAG‐GEFI encoding gene
|
Desai, Amrita |
|
|
1 |
1 |
p. 128-133 |
artikel |
15 |
Platelet‐mapping assay for monitoring antiplatelet therapy during mechanical circulatory support in children: A retrospective observational study
|
Giorni, Chiara |
|
|
1 |
1 |
p. 120-127 |
artikel |
16 |
Research and Practice in Thrombosis and Haemostasis – a new ISTH publishing platform for the global thrombosis and hemostasis community
|
Pabinger, Ingrid |
|
|
1 |
1 |
p. 6-8 |
artikel |
17 |
Secondary prophylaxis decision‐making in venous thromboembolism: interviews on clinical practice in thirteen countries
|
Ten Cate, Vincent |
|
|
1 |
1 |
p. 41-48 |
artikel |
18 |
Statin use and risk of recurrent venous thrombosis: results from the MEGA follow‐up study
|
Brækkan, Sigrid K. |
|
|
1 |
1 |
p. 112-119 |
artikel |
19 |
The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia
|
Arnold, Donald M. |
|
|
1 |
1 |
p. 103-111 |
artikel |
20 |
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban‐treated patients in vitro
|
Schultz, Nina H. |
|
|
1 |
1 |
p. 49-56 |
artikel |
21 |
Treatment of refractory delayed onset heparin‐induced thrombocytopenia after thoracic endovascular aortic repair with intravenous immunoglobulin (IVIG)
|
Doucette, Kimberley |
|
|
1 |
1 |
p. 134-137 |
artikel |